Welcome to Medications.com

Staying at Par? - Motley Fool

Par plans to launch a generic version of GlaxoSmithKline's (NYSE: GSK) Imitrex in the fourth quarter and has a few more possibilities for 2009 and beyond, ...

http://www.fool.com/investing/hig... | Posted: Tue Mar 04 16:11:34 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea